[Targeted molecular therapy: the example of Iressa (ZD1839)]

Med Sci (Paris). 2003 Nov;19(11):1052-4. doi: 10.1051/medsci/200319111052.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / pharmacology*
  • ErbB Receptors / drug effects*
  • ErbB Receptors / physiology
  • Gefitinib
  • Humans
  • Neoplasms / drug therapy
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Quinazolines / pharmacology*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Quinazolines
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • Gefitinib